Latest HIV/Aids posts

Published in SUNS #7195 Thursday 21 July 2011

London/New Delhi, 20 Jul (Sangeeta Shashikant and K. M. Gopakumar) -- There are mixed reactions to the first licensing agreement between Gilead Sciences, one of the world's largest pharmaceutical companies, and the Medicines Patent Pool (MPP), a Swiss foundation, for the production of some HIV/AIDS medicines.

Published in SUNS #6915 dated 30 April 2010

Geneva, 29 Apr (Kanaga Raja) -- Civil society organizations have praised a recent decision by the Ecuadorian government to issue its first compulsory license for lopinavir/ritonavir, a key medication in the treatment of HIV/AIDS.

Welcoming the move by Ecuador, the civil society groups called on other governments in the Latin American region to use compulsory licenses and parallel importation to improve access to essential medicines.

Cordaid and Partners reward Home Based Care Leadership in responding to HIV and AIDS. Win up to 15.000 Euro!

About Caring
 

AIDS has changed the fabric of communities around the world and placed a burden on the lives of many people, especially girls and women, young and old. With health systems failing and people living longer with HIV thanks to access to Antiretrovirals (ARVs), mainly poor women, are increasingly forced to devote their time, energy, skills and the little resources to care for their family members at home and provide their services to the wider community, often at great expense to themselves. This invisible task-shifting is insufficiently recognised, valued and validated as work.

Korean patients and activists are calling for "The Global Action Week Against Roche 1st-7th October 2008" to urge Roche to stop abuse their power and threaten HIV patients, starting with October 1st, the anniversary day of establishment of Roche.

Background